A novel biophysical simulation model predicts consistent lung delivery of QVA149, glycopyrronium and indacaterol via the Breezhaler® device
Andreas Kuttler, Thomas Dimke
European Respiratory Journal 2014 44: P942; DOI:
Andreas Kuttler
1AQS Management, Novartis Pharma AG, Basel, Switzerland
Thomas Dimke
1AQS Management, Novartis Pharma AG, Basel, Switzerland
Vol 44 Issue Suppl 58
Table of Contents
A novel biophysical simulation model predicts consistent lung delivery of QVA149, glycopyrronium and indacaterol via the Breezhaler® device
Andreas Kuttler, Thomas Dimke
European Respiratory Journal Sep 2014, 44 (Suppl 58) P942;